Wolfe Research initiated coverage of 89bio (ETNB) with an Outperform rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on ETNB: 89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’ Biotech Alert: Searches spiking for these stocks today Akero upgraded to Buy at BofA after ‘transformative’ liver data 89bio price target raised to $34 from $30 at BofA 89bio 21.7M share Secondary priced at $8.75 Disclaimer & DisclosureReport an Issue
